EDITAS MEDICINE INC (EDIT) Stock Analyst Earnings Estimates
NASDAQ:EDIT - Nasdaq - US28106W1036 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.71M -22.83% | 78.123M 296.36% | 32.314M -58.64% | 12.667M -60.80% | 11.191M -11.65% | 17.183M 53.54% | 11.016M -35.89% | 16.371M 48.61% | 37.38M 128.33% | 85.382M 128.42% | 160.11M 87.52% | |
| EBITDA YoY % growth | -219.61M -16.75% | -163.117M 25.72% | -233.111M -42.91% | -150.042M 35.63% | -130.869M 12.78% | -103.448M 20.95% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -225.95M -16.98% | -169.181M 25.12% | -238.92M -41.22% | -161.044M 32.60% | -123.239M 23.47% | -139.771M -13.41% | -163.694M -17.12% | -178.608M -9.11% | -189.276M -5.97% | -181.175M 4.28% | -148.516M 18.03% | |
| Operating Margin | -1,146.37% | -216.56% | -739.37% | -1,271.37% | -1,101.23% | -813.42% | -1,485.96% | -1,091.00% | -506.36% | -212.19% | -92.76% | |
| EPS YoY % growth | -3.21 -12.63% | -2.05 36.14% | -2.88 -40.49% | -1.83 36.30% | -1.15 37.56% | -1.13 1.67% | -1.05 7.02% | -1.07 -2.27% | -1.13 -5.08% | -1.00 11.18% | -0.81 19.05% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 53.09% | -0.33 56.36% | -0.22 59.81% | -0.33 64.08% | -0.43 -11.38% | -0.43 -30.88% | -0.08 63.09% |
| Revenue Q2Q % growth | 1.703M 231.97% | 1.805M 2,859.02% | 7.916M -74.13% | 2.081M -55.32% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -37.773M 45.31% | -31.869M 47.96% | -8.675M 69.62% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -35.306M 50.90% | -30.597M 53.41% | -22.864M 33.46% | -29.829M 15.52% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.92 -21.05% | -0.60 | -0.32 | -53.11% |
| Q4 2024 Q2Q % growth | -0.55 -139.13% | -0.36 | -0.19 | -51.16% |
| Q3 2024 Q2Q % growth | -0.75 -36.36% | -0.76 | 0.01 | 1.53% |
| Q2 2024 Q2Q % growth | -0.82 -46.43% | -0.72 | -0.10 | -14.27% |
| Q1 2024 Q2Q % growth | -0.76 -7.04% | -0.68 | -0.08 | -12.10% |
| Q4 2023 Q2Q % growth | -0.23 73.86% | -0.55 | 0.32 | 58.41% |
| Q3 2023 Q2Q % growth | -0.55 32.10% | -0.58 | 0.03 | 5.09% |
| Q2 2023 Q2Q % growth | -0.56 28.21% | -0.78 | 0.22 | 28.06% |
| Q1 2023 Q2Q % growth | -0.71 4.05% | -0.80 | 0.09 | 11.21% |
| Q4 2022 Q2Q % growth | -0.88 -44.26% | -0.82 | -0.06 | -7.53% |
| Q3 2022 Q2Q % growth | -0.81 -42.11% | -0.89 | 0.08 | 8.60% |
| Q2 2022 Q2Q % growth | -0.78 3.70% | -0.84 | 0.06 | 6.94% |
| Q1 2022 Q2Q % growth | -0.74 13.95% | -0.81 | 0.07 | 8.76% |
| Q4 2021 Q2Q % growth | -0.61 39.00% | -0.74 | 0.13 | 17.05% |
| Q3 2021 Q2Q % growth | -0.57 -575.00% | -0.83 | 0.26 | 31.53% |
| Q2 2021 Q2Q % growth | -0.81 -88.37% | -0.84 | 0.03 | 3.98% |
| Q1 2021 Q2Q % growth | -0.86 -24.64% | -0.75 | -0.11 | -14.81% |
| Q4 2020 Q2Q % growth | -1.00 -35.14% | -0.75 | -0.25 | -33.14% |
| Q3 2020 Q2Q % growth | 0.12 118.18% | -0.65 | 0.77 | 118.50% |
| Q2 2020 Q2Q % growth | -0.43 37.68% | -0.82 | 0.39 | 47.74% |
| Q1 2020 Q2Q % growth | -0.69 -15.00% | -0.80 | 0.11 | 14.06% |
| Q4 2019 Q2Q % growth | -0.74 | -0.11 | -0.63 | -593.12% |
| Q3 2019 Q2Q % growth | -0.66 | -0.74 | 0.08 | 10.69% |
| Q2 2019 Q2Q % growth | -0.69 | -0.64 | -0.05 | -8.02% |
| Q1 2019 Q2Q % growth | -0.60 | -0.60 | 0.00 | 0.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 4.658M 310.40% | 720.12K | 3.938M | 546.84% |
| Q4 2024 Q2Q % growth | 30.604M -49.03% | 32.875M | -2.271M | -6.91% |
| Q3 2024 Q2Q % growth | 61K -98.86% | 2.289M | -2.228M | -97.34% |
| Q2 2024 Q2Q % growth | 513K -82.23% | 5.185M | -4.672M | -90.11% |
| Q1 2024 Q2Q % growth | 1.135M -88.48% | 8.063M | -6.928M | -85.92% |
| Q4 2023 Q2Q % growth | 60.048M 818.17% | 8.102M | 51.946M | 641.15% |
| Q3 2023 Q2Q % growth | 5.336M 13,240.00% | 3.488M | 1.848M | 52.98% |
| Q2 2023 Q2Q % growth | 2.887M -54.61% | 4.254M | -1.367M | -32.13% |
| Q1 2023 Q2Q % growth | 9.851M 45.51% | 3.068M | 6.783M | 221.09% |
| Q4 2022 Q2Q % growth | 6.54M -47.55% | 3.323M | 3.217M | 96.81% |
| Q3 2022 Q2Q % growth | 40K -99.35% | 4.801M | -4.761M | -99.17% |
| Q2 2022 Q2Q % growth | 6.36M 1,573.68% | 4.376M | 1.984M | 45.34% |
| Q1 2022 Q2Q % growth | 6.77M 4.15% | 3.93M | 2.84M | 72.26% |
| Q4 2021 Q2Q % growth | 12.47M 9.19% | 4.372M | 8.098M | 185.22% |
| Q3 2021 Q2Q % growth | 6.2M -90.13% | 4.872M | 1.328M | 27.26% |
| Q2 2021 Q2Q % growth | 380K -96.47% | 6.299M | -5.919M | -93.97% |
| Q1 2021 Q2Q % growth | 6.5M 13.64% | 5.891M | 609K | 10.34% |
| Q4 2020 Q2Q % growth | 11.42M -7.00% | 5.756M | 5.664M | 98.40% |
| Q3 2020 Q2Q % growth | 62.84M 1,532.21% | 6.732M | 56.108M | 833.45% |
| Q2 2020 Q2Q % growth | 10.75M 361.37% | 6.462M | 4.288M | 66.36% |
| Q1 2020 Q2Q % growth | 5.72M 176.33% | 6.86M | -1.14M | -16.62% |
| Q4 2019 Q2Q % growth | 12.28M | 45.507M | -33.227M | -73.02% |
| Q3 2019 Q2Q % growth | 3.85M | 4.811M | -961K | -19.98% |
| Q2 2019 Q2Q % growth | 2.33M | 6.018M | -3.688M | -61.28% |
| Q1 2019 Q2Q % growth | 2.07M | 6.477M | -4.407M | -68.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 10.35% | 0% | -18.13% |
| Revenue | 0.24% | 29.8% | 0.02% | 47.29% |